Contact Us
Please complete the form, and a representative of Intelligent Bio Solutions will contact you shortly to assist with your enquiry.
Our Locations
New York
Intelligent Bio Solutions Inc.
Floor 5, 135 W 41st St,
New York, NY 10036,
United States
+1 646 790 5756
Office Hours
9am – 5pm Monday to Friday
Sydney
Intelligent Bio Solutions Inc.
Level 1, Suite 5,
28-40 Lord Street,
Botany, NSW, 2019
Australia
Office Hours
9am – 5pm Monday to Friday
Cambridge
14-17 Evolution Business Park,
Milton Road, Impington,
Cambridge, CB24 9NG,
United Kingdom
info@intelligentfingerprinting.com
+44 (0)1223 941941
Office Hours
9am – 5pm Monday to Friday
Media Contact
For media enquiries, please contact marketing@ibs.inc.
Investor Contact
Valter Pinto, Managing Director
KCSA Strategic Communications
Find more information at investors.ibs.inc.
Connect With Us
Latest News
Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission
NEW YORK, June 02, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the initiation of a multi-site Method Comparison Study to support its FDA 510(k) submission for U.S. market clearance of its Intelligent Fingerprinting Drug Screening System for the…
Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year
NEW YORK, May 13, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its financial results and operational highlights for the fiscal third quarter and nine months ended March 31, 2026, and provided a business update. “The third quarter marked…
Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results
NEW YORK, April 20, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the launch of a validation study aimed at significantly reducing the analysis time of its Intelligent Fingerprinting Drug Screening System. The study aims to improve the already…